Nalaganje...

Immunotherapy and pancreatic cancer: unique challenges and potential opportunities

Despite decades of research, pancreatic ductal adenocarcinoma (PDAC) continues to have the worst 5-year survival of any malignancy. With 338,000 new cases diagnosed and over 300,000 deaths per year globally there is an urgent unmet need to improve the therapeutic options available. Novel immunothera...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ther Adv Med Oncol
Main Authors: Young, Kate, Hughes, Daniel J., Cunningham, David, Starling, Naureen
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6299311/
https://ncbi.nlm.nih.gov/pubmed/30574212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918816281
Oznake: Označite
Brez oznak, prvi označite!